Atropine sulfate opthalmic - Seefunge Pharmaceutical Technology
Alternative Names: Atropine sulfate eye drops - Seefunge Pharmaceutical Technology; OS-001Latest Information Update: 03 Feb 2025
Price :
$50 *
At a glance
- Originator Seefunge Pharmaceutical Technology
- Class Alkaloids; Antidotes; Cardiovascular therapies; Eye disorder therapies; Small molecules; Tropanes
- Mechanism of Action Cholinergic receptor antagonists; Muscarinic receptor antagonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Phase III Myopia
Most Recent Events
- 13 Dec 2024 Chemical structure information added.
- 15 Jun 2024 Phase-III clinical trials in Myopia (In children) in China (Ophthalmic) (NCT06708156)